» Articles » PMID: 29921869

Tubular Iron Deposition and Iron Handling Proteins in Human Healthy Kidney and Chronic Kidney Disease

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jun 21
PMID 29921869
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Iron is suggested to play a detrimental role in the progression of chronic kidney disease (CKD). The kidney recycles iron back into the circulation. However, the localization of proteins relevant for physiological tubular iron handling and their potential role in CKD remain unclear. We examined associations between iron deposition, expression of iron handling proteins and tubular injury in kidney biopsies from CKD patients and healthy controls using immunohistochemistry. Iron was deposited in proximal (PT) and distal tubules (DT) in 33% of CKD biopsies, predominantly in pathologies with glomerular dysfunction, but absent in controls. In healthy kidney, PT contained proteins required for iron recycling including putative iron importers ZIP8, ZIP14, DMT1, iron storage proteins L- and H-ferritin and iron exporter ferroportin, while DT only contained ZIP8, ZIP14, and DMT1. In CKD, iron deposition associated with increased intensity of iron importers (ZIP14, ZIP8), storage proteins (L-, H-ferritin), and/or decreased ferroportin abundance. This demonstrates that tubular iron accumulation may result from increased iron uptake and/or inadequate iron export. Iron deposition associated with oxidative injury as indicated by heme oxygenase-1 abundance. In conclusion, iron deposition is relatively common in CKD, and may result from altered molecular iron handling and may contribute to renal injury.

Citing Articles

Intricating connections: the role of ferroptosis in systemic lupus erythematosus.

Zhao G, Li X, Zhang Y, Wang X, Deng L, Xu J Front Immunol. 2025; 16:1534926.

PMID: 39967676 PMC: 11832682. DOI: 10.3389/fimmu.2025.1534926.


Evaluation of iron deposition in diabetic kidney disease using the kidney-to-muscle signal intensity ratio on routine MRI T2WI sequences.

Chu J, Guo A, Hu S, Ma Y, Yang F, Xiao W Abdom Radiol (NY). 2025; .

PMID: 39928100 DOI: 10.1007/s00261-025-04827-w.


Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression.

Jin R, Dai Y, Wang Z, Hu Q, Zhang C, Gao H Biology (Basel). 2025; 14(1).

PMID: 39857243 PMC: 11763183. DOI: 10.3390/biology14010012.


Evaluation of hypoxia-inducible factor-1α and urine non-transferrin-bound iron concentrations in cats with chronic kidney disease.

Chen C, Hsu W, Tsai P, Lai C, Wu M, Lee Y Front Vet Sci. 2025; 11:1482998.

PMID: 39748872 PMC: 11694447. DOI: 10.3389/fvets.2024.1482998.


Mammalian SLC39A13 promotes ER/Golgi iron transport and iron homeostasis in multiple compartments.

Li H, Cui Y, Hu Y, Zhao M, Li K, Pang X Nat Commun. 2024; 15(1):10838.

PMID: 39738060 PMC: 11685566. DOI: 10.1038/s41467-024-55149-2.


References
1.
Ruggenenti P, Cravedi P, Remuzzi G . Mechanisms and treatment of CKD. J Am Soc Nephrol. 2012; 23(12):1917-28. DOI: 10.1681/ASN.2012040390. View

2.
Wagner M, Ashby D, Kurtz C, Alam A, Busbridge M, Raff U . Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease. PLoS One. 2015; 10(4):e0123072. PMC: 4404250. DOI: 10.1371/journal.pone.0123072. View

3.
Starzynski R, Canonne-Hergaux F, Lenartowicz M, Krzeptowski W, Willemetz A, Stys A . Ferroportin expression in haem oxygenase 1-deficient mice. Biochem J. 2012; 449(1):69-78. DOI: 10.1042/BJ20121139. View

4.
Norden A, Lapsley M, Lee P, Pusey C, Scheinman S, Tam F . Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 2001; 60(5):1885-92. DOI: 10.1046/j.1523-1755.2001.00016.x. View

5.
Ueda N, Baliga R, Shah S . Role of 'catalytic' iron in an animal model of minimal change nephrotic syndrome. Kidney Int. 1996; 49(2):370-3. DOI: 10.1038/ki.1996.54. View